HealthEquity, Inc (HQY) PT Raised to $77 at Chardan Capital Markets

Chardan Capital Markets raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $77.00 (from $62.00) while maintaining a Buy rating.

Analyst Steven Wardell comments "We liked the strong demand we are seeing from the marketplace and strong execution from Management. We raise our PT at $77 based on earnings growth through FY21E and multiple expansion that will bring HQY's valuation to a slight premium over its peers."

You May Also Be Interested In

• Teradata (TDC) PT Lowered to $32 at UBS on Cautious Q3 View
• BofA Securities Starts Ather Energy Ltd (ATHERENE:IN) at Buy
• BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy